Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants', signaling that the study is not enrolling any more participants. The change log also adds a new revision tag v3.6.0 and removes the previous v3.5.5 tag.SummaryDifference0.6%

- Check11 days agoChange DetectedA new page revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed from the current history snapshot.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a new revision tag, v3.5.4, replacing the previous v3.5.3. This indicates a routine platform update rather than a modification to the study record itself.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a minor website software/version update to how the history page is presented.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check69 days agoChange DetectedDifference0.1%

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.